In UDCA-treated LLC tumor-bearing mice, a decrease in CD4+ CD25+ Foxp3+ Treg cells among tumor-infiltrating leukocytes (TILs) was observed (Fig. 1b). This evidence concerns the gene CD4 and neoplasm.